What is FMS's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 10.22B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for FMS?

P/E (TTM) is 10.89 and 52-week range is €34.57 to €47.54 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s FMS figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for FMS?

The company profile lists revenue (TTM) near $19.44B, net income (TTM) near $939M, EPS (TTM) near €3.33 when available from the market-data feed. Figures are informational and may lag live markets.

Does FMS show a dividend on Chartloom?

The overview lists dividend per share (TTM) near €1.43, yield near 3.92%, ex-dividend date May 22, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Fresenius Medical Care AG based, and what identifiers does Chartloom list?

The company context section lists headquarters in Bad Homburg vor der Hohe, Hessen, DE, 268.6M shares outstanding, ISIN DE0005785802 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Fresenius Medical Care AG

$FMS

Health Care · Health Care Providers & Services

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Employees

109,698

Website

www.freseniusmedicalcare.com/

IPO

1996-10-02

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

XETRA

ISIN

DE0005785802

Headquarters

Bad Homburg vor der Hohe, Hessen, DE

Shares outstanding

268.6M

NAICS sector

Health Care and Social Assistance

Institutional ownership

49.55%

Browse other companiesFree AI scores and summaries for more stocks